Mallon Mark 4
4 · NEOGENOMICS INC · Filed Dec 30, 2021
Insider Transaction Report
Form 4
Mallon Mark
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2021-12-30+152,858→ 225,594 total
Holdings
- 151,016
Stock Option (Right to Buy)
Exercise: $49.34Exp: 2028-04-19→ Common Stock (151,016 underlying)
Footnotes (2)
- [F1]On December 30, 2021, Mr. Mallon was granted 152,858 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
- [F2]On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.